Regorafenib (Stivarga)

1 / 1
Share this content:

This slideshow examines regorafenib (Stivarga), indicated for the treatment of patients with metastatic colorectal cancer (CRC) or metastatic gastrointestinal stromal tumor (GIST) .


Table of Contents

Slide 4: Indication, Dosage, and Administration
Slide 11: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 27: References


 


You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs